Treatment Set TS340153

Product NDC

49288-0808

11-digit product format

492880808

Labeler code

49288

Product ID

49288-0808_ae8520ee-f4a4-4de4-9d2d-bccc97d30931

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Treatment Set TS340153

Dosage form

INJECTION, SOLUTION

Route

INTRADERMAL; SUBCUTANEOUS

Labeler

Antigen Laboratories, Inc.

Application

BLA102223

Marketing category

BLA

Marketing start

1986-10-31

Marketing end

0000-00-00

Substance

CARYA TOMENTOSA POLLEN; CARYA ILLINOINENSIS POLLEN; ULMUS AMERICANA POLLEN; SALSOLA KALI POLLEN; PLATANUS OCCIDENTALIS POLLEN; JUGLANS NIGRA POLLEN

Active strength

0 g/mL; g/mL; g/mL; g/mL; g/mL; g/mL

Pharmacologic classes

Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]

NDC exclude flag

E

Listing certified through

2017-12-31

Current FDA listing

Historical FDA.report record